DrugDashboards

Hyoscyamine Sulfate

Hyoscyamine Sulfate · HYOSCYAMINE SULFATE .125 mg/1 · Tablet · Oral · Proficient Rx LP

NDC 82804-0965-30 · 30 TABLET in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for hyoscyamine sulfate (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Hyoscyamine Sulfate (Tablet)

LabelerStrengthFirst seenLast seen
Acella Pharmaceuticals, LLCHYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 3, 2026
ANI Pharmaceuticals, Inc.HYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackHYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 3, 2026
Granulation Technology, Inc.HYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 3, 2026
NCS HealthCare of KY, LLC dba Vangard LabsHYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 3, 2026
Northwind Health Company, LLCHYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 3, 2026
Patrin Pharma, Inc.HYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 3, 2026
Westminster Pharmaceuticals, LLCHYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 3, 2026
Larken Laboratories, Inc.HYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPHYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 2, 2026
QPharma, Inc.HYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 2, 2026
Viatris Specialty LLCHYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCHYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Aug 31, 2026
Remedyrepack Inc.HYOSCYAMINE SULFATE .125 mg/1Jul 15, 2026Aug 29, 2026
Redpharm DrugHYOSCYAMINE SULFATE .125 mg/1Aug 7, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Hyoscyamine Sulfate — NDC 82804-0965-30," retrieved September 3, 2026, https://drugdashboards.com/drug/82804096530.

Free to cite with attribution — see how the data is put together.